Adham Ahmed

Adham Ahmed

Auto-generated profile, based on publicly available information

Adham Ahmed

Department of Cardiothoracic Surgery, Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2021 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
AAAdham Ahmed
Adham Ahmed
KLKenneth H. Levy
Kenneth H. Levy

13 March 2023 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
AAAdham Ahmed
Adham Ahmed
DMDave M Mathew
Dave M Mathew
SMSerena M Mathew
Serena M Mathew
AAAhmed K Awad
Ahmed K Awad
KVKathryn S Varghese
Kathryn S Varghese
PFPeter J Fusco
Peter J Fusco

10 June 2023 in Seminars in Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
DMDave M Mathew
Dave M Mathew
PFPeter J Fusco
Peter J Fusco
KVKathryn S Varghese
Kathryn S Varghese
AAAhmed K Awad
Ahmed K Awad
EVEamon Vega
Eamon Vega
AAAdham Ahmed
Adham Ahmed
Background: Despite their extensive clinical use, opioids are characterized by several side effects. These complications, coupled with the ongoing opioid epidemic, have favored the rise of opioid-free-anesthesia (OFA). Herein, we perform the first pairwise meta-analysis of clinical outcomes for OFA vs opioid-based anesthesia (OBA) in patients undergoing cardiovascular and thoracic surgery. Methods: We comprehensively searched medical databases to identify studies comparing OFA and OBA in patients undergoing cardiovascular or thoracic surgery. Pairwise meta-analysis was performed using the Mantel–Haenszel method. Outcomes were pooled as risk ratios (RR) or standard mean differences (SMD) and their 95% confidence intervals (95% CI). Results: Our pooled analysis included 919 patients (8 studies), of whom 488 underwent surgery with OBA and 431 with OFA. Among cardiovascular surgery patients, compared to OBA, OFA was associated with significantly reduced post-operative nausea and vomiting (RR, 0.57; P = .042), inotrope need (RR .84, P = .045), and non-invasive ventilation (RR, .54; P = .028). However, no differences were observed for 24hr pain score (SMD, −.35; P = .510) or 48hr morphine equivalent consumption (SMD, −1.09; P = .139). Among thoracic surgery patients, there was no difference between OFA and OBA for any of the explored outcomes, including post-operative nausea and vomiting (RR, 0.41; P = .025). Conclusion: Through the first pooled analysis of OBA vs OFA in a cardiothoracic-exclusive cohort, we found no significant difference in any of the pooled outcomes for thoracic surgery patients. Although limited to 2 cardiovascular surgery studies, OFA was associated with significantly reduced postoperative nausea and vomiting, inotrope need, and non-invasive ventilation in these patients. With growing use of OFA in invasive operations, further studies are needed to assess their efficacy and safety in cardiothoracic patients.

7 September 2021 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
IHIrbaz Hameed
Irbaz Hameed
COChristian T. Oakley
Christian T. Oakley
NHN. U. Farrukh Hameed
N. U. Farrukh Hameed
AAAdham Ahmed
Adham Ahmed
NNNyla Naeem
Nyla Naeem
PVPrashanth Vallabhajosyula
Prashanth Vallabhajosyula

6 July 2023 in General Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
AAAdham Ahmed
Adham Ahmed
AAAhmed K. Awad
Ahmed K. Awad
KVKathryn S. Varghese
Kathryn S. Varghese
VSViren S. Sehgal
Viren S. Sehgal
KHKenzy Hisham
Kenzy Hisham
DMDave M. Mathew
Dave M. Mathew

9 February 2025 in JACC: Advances
Verified
Journal Article
Open access
IHIrbaz Hameed
Irbaz Hameed
AAAdham Ahmed
Adham Ahmed
CWChristina Waldron
Christina Waldron
PAPercy T. Algarate
Percy T. Algarate
MKMichal Kawczynski
Michal Kawczynski
AGArnar Geirsson
Arnar Geirsson
Despite strong recommendations from multiple societies to pursue durable mitral valve repair (MVr), repair rates and outcomes remain inconsistent across the world. This is partly due to limited surgeon and center experience and lack of centralization of care for this technically challenging operation. The authors evaluate the association between annual case volume and contemporary long-term outcomes of patients undergoing isolated MVr. A systematic literature search was performed to identify contemporary studies on isolated MVr in adults from January 2013 to November 2023. The primary outcomes were long-term survival, freedom from reoperation, and freedom from recurrent mitral regurgitation (moderate-severe). A novel meta-analytic volume-outcome approach using reconstructed Kaplan-Meier-derived individual patient data from the original studies was used. A frailty Cox model was applied to study volume-outcome relationships. Studies were pooled for each reported outcome and divided into 3 tertiles (T1-3) based on the annual case volume and number of patients of each center. A total of 14,070 patients from 60 studies were pooled. Sixteen studies (6,099 patients) reported long-term survival. The overall pooled 10-year survival was 70.8% (95% CI: 68.9%-72.8%). Compared to lower volume centers, centers performing >38 cases/y were associated with significantly improved long-term survival (HR: 0.42; 95% CI: 0.36-0.49; P < 0.001). For degenerative mitral valve disease, a volume cutoff of >45 cases/y was associated with significantly improved long-term survival (HR: 0.40; 95% CI: 0.32-0.49; P < 0.001). Twelve studies (4,230 patients) reported long-term freedom from reoperation and 10 studies (2,470 patients) reported Kaplan-Meier-derived long-term freedom from recurrent mitral regurgitation data, respectively. The overall pooled 10-year freedom from reoperation was 90.2% (95% CI: 88.1%-92.4%), while the overall pooled 10-year freedom from recurrent mitral regurgitation was 72.7% (95% CI: 68.9%-76.8%). Centers performing >45 cases/y (HR: 0.61; 95% CI: 0.44-0.84; P = 0.003) and >70 cases/y (HR: 0.64; 95% CI: 0.42-0.98; P = 0.042) were associated with significantly improved long-term freedom from recurrent mitral regurgitation and freedom from reoperation, respectively. For degenerative mitral disease, >45 cases/y was associated with significantly improved freedom from recurrent mitral regurgitation (HR: 0.51; 95% CI: 0.36-0.72; P < 0.001); the volume outcome association for freedom from reoperation was not statistically significant (P = 0.58). Our study validates volume cutoffs associated with optimal long-term outcomes following isolated MVr. We found MVr volumes of >38 cases/y, 45 cases/y, and >70 cases/y to be associated with significantly improved long-term survival, durability of repair, and freedom from reoperation, respectively. These findings may define experienced centers and surgeons for patients requiring MVr for primary/degenerative mitral valve disease.